Supreme Court rejects Musk appeal over Tesla tweets
WASHINGTON (AP) — The Supreme Court on Monday rejected an appeal from Elon Musk over a settlement with securities regulators that requires him to get approval in advance of some tweets that relate to Tesla, the electric vehicle company he leads.
The justices did not comment in leaving in place lower-court rulings against Musk, who complained that the requirement amounts to “prior restraint” on his speech in violation of the First Amendment.
The case stems from tweets Musk posted in 2018 in which he claimed he had secured funding to take Tesla private. The tweets caused the company’s share price to jump and led to a temporary halt in trading.
The settlement with the Securities and Exchange Commission included a requirement that his tweets be approved first by a Tesla attorney. It also called for Musk and Tesla to pay civil fines over the tweets in which Musk said he had “funding secured” to take Tesla private at $420 per share.
Related articles
Justin Timberlake set to bring his The Forget Tomorrow World Tour to Australia in 2025
Justin Timberlake is set to bring his The Forget Tomorrow World Tour to Australia next year.Daily Ma2024-05-21Wood scores 11:03 in OT as Avalanche finish off 3
DALLAS (AP) — Miles Wood screamed for the puck, and delivered the game-winner in overtime for the Co2024-05-21Plastic surgeons reveal which Met Gala celebs they think may be using Ozempic
Kim Kardashian's ultra-thin waist may have stolen the headlines when it came to dramatic body change2024-05-21Court rules North Carolina Catholic school could fire gay teacher who announced his wedding online
RALEIGH, N.C. (AP) — A Catholic school in North Carolina had the right to fire a gay teacher who ann2024-05-21A warrant for Netanyahu’s arrest was requested. But no decision was made about whether to issue it
CLAIM: The International Criminal Court issued an arrest warrant for Israeli Prime Minister Benjamin2024-05-21AstraZeneca pulls COVID vaccine from European market
LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COV2024-05-21
atest comment